ProJenX Announces First Person Dosed in Phase 1 Study of Prosetin
/PRNewswire/ -- ProJenX, a clinical stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the...
Source: prnewswire.com
Stay updated with breaking news from Projenx Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ProJenX, a clinical stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the...
/PRNewswire/ -- ProJenX, a New York City-based, clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined...